So you feel full longer, and you eat less food as a result
At The Peptide Labs, we created this guide to break down the key differences between GHK-Cu vs BPC-157 , including research focus, reconstitution, common protocol structure, tissue targets, and how each peptide may fit different research goals
B12 testing is recommended in patients with fatty liver disease who have: Symptoms suggestive of deficiency (anaemia, neuropathy, cognitive changes) Long-term metformin use (MHRA 2022 guidance advises monitoring) Long-term proton pump inhibitor use Vegetarian or vegan diets Conditions affecting absorption (pernicious anaemia, coeliac disease, gastric surgery) Advanced liver disease (NASH, fibrosis, or cirrhosis) Monitoring frequency should be individualised based on disease severity and risk factors
This gatekeeping approach means patients with A1C levels between 5.7% and 6.4%the clinical definition of prediabetesfall outside covered indications, even though clinical evidence supports early intervention
A, 312
This peptide-pathway genetic assessment (different from pharmacogenomic testing) identifies how your biology influences GLP-1 response, GIP sensitivity, and appetite-regulation mechanisms
